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Introduction {#sec1}
============

DNA recombineering was first developed in the early 2000s ([@bib12], [@bib44]) as a genetic technology for replacing genomic segments of *E. coli* with synthetic double-stranded (ds) DNA by means of the DNA exchange mechanism brought about by the Red system of phage lambda. Although the native approach involves three proteins (a β-recombinase, an exonuclease, and the γ protein, which protects free ds ends of DNA from degradation by RecBCD), it turned out that the Red-β protein sufficed to promote invasion of the replication fork by single-stranded (ss) oligonucleotides incorporated as Okazaki fragments ([@bib13]). If such oligonucleotides were designed to carry mutations, the resulting changes could be inherited at considerable frequencies upon subsequent rounds of DNA segregation. The key value of this approach is that by using cocktails of mutagenic oligonucleotides and either manual or automated cycles of Red expression/oligonucleotide transformation one can enter simultaneous changes in many genomic sites and/or saturate given DNA stretches with specific or random mutations ([@bib41], [@bib29], [@bib30]). This technology gave rise to MAGE (multiplex automated genome engineering) in *E. coli*, a cycled and multiplexed application of recombineering that exploits the capabilities of the Red system for large-scale reprogramming of cells, i.e., metabolic engineering of lycopene production ([@bib41]) or genome-wide codon replacements ([@bib17]). These methods have been improved further by using host strains transiently disabled in mismatch repair (MMR) and by enriching mutants through Cas9/guide RNA-based counterselection of wild-type sequences ([@bib11], [@bib18], [@bib28], [@bib29], [@bib34], [@bib31]). These technologies work well in *E. coli*, whereas they are difficult to transplant directly to non-enteric bacteria. Yet, their applicability to species such as *Pseudomonas putida* has a special interest because of the value of environmental microorganisms as useful platforms for metabolic engineering ([@bib26], [@bib27], [@bib24]). Attempts of functional expression of the lambda Red system in various species of *Pseudomonas* have been reported, but recombination frequencies were low in the absence of selection ([@bib20], [@bib21], [@bib23], [@bib10], [@bib43]). Red-like counterparts found in *Pseudomonas* prophages have been more successful to the same ends. For example, the RecET recombinase/exonuclease pair of *P. syringae* has been instrumental for executing a suite of manipulations in this species ([@bib37], [@bib5]). Furthermore, bioinformatic mining of *Pseudomona*s-borne recombinases from known protein families (i.e., Redβ, ERF, GP2.5, SAK, and SAK4; [@bib22]) followed by experimental validation of the most promising in a standardized recombineering test exposed two new enzymes (Ssr and Rec2: [@bib1], [@bib33], [@bib4]). These recombinases delivered a comparatively high level of activity in the reference strains *P. putida* KT2440 and its genome-reduced derivative *P. putida* EM42. Still, numbers were way below those reported for *E. coli.* Furthermore, the action of the endogenous MMR system of this bacterium impeded single-nucleotide changes (i.e., A to T, mismatch A:A) that were efficiently fixed by the indigenous *mutS/mutL* device ([@bib1], [@bib3]).

In this work we have set out to overcome the above-mentioned bottlenecks to efficacious recombineering in *P. putida*. The approach builds on the apparently superior ability of the Rec2 recombinase to promote DNA annealing with exogenous synthetic oligonucleotides during chromosomal replication. By playing with a stringent expression system for *rec2*, applying multiple cycles of recombinase production/oligonucleotide transformation, and reversibly inhibiting the MMR system during a limited time window we report in the following discussion high-fidelity recombination frequencies that approach those achieved with the archetypal Red-based system ([@bib12]). This opens genome editing possibilities in this environmental bacterium that were thus far limited to strains of *E. coli*, closely related enteric species ([@bib30], [@bib39]), and some lactic acid bacteria ([@bib40]).

Results {#sec2}
=======

Optimization of Rec2 and MutL~E36K~^PP^ Delivery for ssDNA Recombineering {#sec2.1}
-------------------------------------------------------------------------

The bicistronic gene cassette of pSEVA2514-*rec2*-*mutL*~E36K~^PP^ ([Figure 1](#fig1){ref-type="fig"}A) was developed earlier for examining the hierarchy of recognition of different types of single-nucleotide mispairs by the native MMR system of *P. putida* ([@bib3]). In this construct *rec2* and *mutL*~E36K~^PP^ were placed under the control of the thermo-inducible P~*L*~/*c*I857 system, in which the product of *c*I857 represses the P~*L*~ promoter at 30°C but becomes inactivated at 42°C, triggering the expression of the genes after a short thermal shift. During the course of that work, we noticed that a short, transient thermal induction of the Rec2 recombinase increased very significantly ssDNA recombineering (∼1 order of magnitude) when compared with the same with an expression device responsive to 3-methylbenzoate (i.e., *xylS*/P*m*). Although the reason for this improvement is not entirely clear, it may have resulted from (1) the short-lived, high-level transcription of the otherwise toxic recombinase---when compared with the permanent hyperexpression caused by the chemically inducible system; (2) thermal inactivation of ssDNA nucleases and thus improved survival of the mutagenic oligonucleotides *in vivo;* or (3) a combination of both. In any case, the average frequency of single-base replacements in just one single-shot recombineering test was in the range of 1 × 10^−2^ mutants per viable cell. This was high when compared with previous recombineering efforts in this bacterium ([@bib1]) but still low for identifying mutations without a selectable phenotype. We, however, speculated that by multi-cycling the procedure with short thermal pulses of recombinase induction and transformation with mutagenic oligos, such frequencies could be added at each cycle, eventually resulting in high nucleotide replacement rates. A second realization ([@bib3]) was that transient co-expression of the dominant allele MutL~E36K~^PP^ of the MMR system of *P. putida* along with the *rec2* gene in plasmid pSEVA2514-*rec2*-*mutL*~E36K~^PP^ ([Figure 1](#fig1){ref-type="fig"}) virtually eliminated recognition of any type of base mispairings in DNA. This allowed entering all classes of nucleotide replacements that would otherwise be conditioned by MMR---without triggering a general mutagenic regime. Yet, note that both activities (Rec2 and MutL~E36K~^PP^) were delivered *in vivo* with a high-copy-number vector with an origin or replication (RSF1010) of unknown thermal sensitivity. This may result in some instability upon thermal cycling of the procedure for boosting recombineering efficiency (see below). To determine the best plasmid frame for *rec2*-*mutL*~E36K~^PP^ transient expression, the cognate DNA segment was recloned in vectors pSEVA2214 (RK2 origin or replication, low copy number) and pSEVA2314 (pBBR1 origin, medium copy number) as shown in [Figure 1](#fig1){ref-type="fig"}A. Recombineering tests were then carried out with oligonucleotide NR, which generated a double mutation in *gyrA* endowing resistance to nalidixic acid (Nal^R^) by means of two MMR-sensitive changes G → A and C → T. In parallel, another MMR-insensitive change A → C was also tested with oligonucleotide SR that mutated *rpsL* for making cells resistant to streptomycin (Sm^R^), and recombineering assays were run in non-induced and heat-induced cultures. The results of this test indicated that thermal induction of *rec2* and *mutL*~E36K~^PP^ genes enhances recombineering by 3--4 logs with efficiencies in the range of 1 × 10^−2^ mutants/viable cell for the three plasmids assayed. Performance comparison points to pSEVA2314-*rec2*-*mutL*~E36K~^PP^ as the preferred construct of reference for the multi-site mutagenesis platform presented in the following discussion. On the basis of this we set out to re-create in *P. putida* the same conditions that enabled implementation in *E. coli* of high-efficiency ssDNA recombineering protocols such as MAGE ([@bib41]), DIvERGE (directed evolution with random genomic mutations; [@bib30]), and pORTMAGE (portable MAGE; [@bib29])---and thus expand frontline genomic editing methods toward this environmentally and industrially important bacterium.Figure 1Influence of Plasmid Copy Number on the Editing Efficiency of the Heat-Induced *rec2-mutL*~E36K~^PP^ Genes(A) Genetic map and structure of plasmids used in this study. The figure shows the plasmids tested, all having the same elements with the exception of the origin of replication, represented with "x." T~0~ and T~1~, transcriptional terminators; Km, kanamycin resistance gene; *ori*T, origin of transfer; *c*I857-P~*L*~, temperature-inducible expression system; *rec2*, recombinase; *mutL*~E36K~^PP^, dominant-negative allele of *mutL*; *ori* x (origin of replication): \#2, RK2 (low copy number); \#3, pBBR1 (medium copy number); \#5, RSF1010 (medium-high copy number). Pictures are not drawn to scale.(B) Recombineering assays with *P. putida* EM42: the strain harboring each pSEVA2x14-*rec2*-*mutL*~E36K~^PP^ variant was subjected to recombineering with oligos SR and NR upon heat induction of the *c*I857-P~*L*~ expression system and without induction. After overnight recovery, culture dilutions were plated on LB-Sm (SR oligo) and LB-Nal (NR oligo) to estimate the number of allelic changes. Culture dilutions plated on LB allowed viable cell counting. Column values represent mean recombineering frequencies (mutants per 10^9^ viable cells) of two independent experiments with the standard deviation.

Cyclic Pulses of rec2/mutL~E36K~^PP^ Expression Enable a High Level of Single-Nucleotide Substitutions {#sec2.2}
------------------------------------------------------------------------------------------------------

The first issue at stake was determining the frequencies of mutations caused by using a cocktail of oligonucleotides targeting five genes representative of diverse genomic locations, different types of nucleotide changes, and associated or not with selectable traits upon multiple ssDNA recombineering cycles. The genes at stake, their position in the chromosomal map, the cognate phenotypes, and the type of replacements brought about by the corresponding mutagenic ssDNAs are summarized in [Figure 2](#fig2){ref-type="fig"}. They were all designed to pair sequences in the lagging strand of the replication fork in each of the replichores of the *P. putida* genome according to [@bib1]. Note that the experiments were run with *P. putida* EM42, not with the archetypal strain KT2440. This is because it is a *recA*^+^ derivative of the EM383 genome-streamlined variant that has higher endogenous levels of ATP and NAD(P)H and has thus become a preferred metabolic engineering platform ([@bib25]). Moreover, the modifications entered in *P putida* EM42 make this strain more tolerant to pulses of high temperature ([@bib2]), as repeatedly applied throughout this work (see later). The cyclic recombineering protocol (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} for details) is summarized in [Figure 3](#fig3){ref-type="fig"}, and it basically involves four steps: (1) growing cells, (2) triggering thermal induction of *rec2* and *mutL*~E36K~^PP^ genes by a short heat shock, (3) preparing competent cells for electroporation with the mutagenic oligonucleotides, and (4) recovering the culture for a new cycle.Figure 2Target Genes and Recombineering Oligonucleotides Used for HEMSE(A) The five genes selected as targets for recombineering are represented in the chromosomal map of *P. putida* KT2440 with gene coordinates and strand orientation. *oriC* and *dif* regions are shown to define the two replichores in the genomic map. Pictures are not drawn to scale.(B) The main features of recombineering oligonucleotides used to assay HEMSE are shown: name of oligo, target gene with its locus tag, type of allelic replacement, level of MMR sensitivity of the allelic changes, and the cognate phenotypes produced. See [Tables S1](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"} for additional information.Figure 3Scheme of HEMSE CycleThe main steps of the procedure are depicted: cultures of *P. putida* EM42 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) grown at OD~600~ = 1.0 are induced by a heat shock at 42°C/15 min; then competent cells are prepared and transformed with recombineering oligonucleotides. After recovery on fresh media at 30°C/170 rpm, cultures enter into the next round of HEMSE by applying the induction step. Screening of allelic replacements within a given cycle is performed after recovery by plating culture dilutions on the appropriate solid media (see [Transparent Methods](#mmc1){ref-type="supplementary-material"} for details).

The results of applying multiple recombineering cycles to *P. putida* EM42 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) with the oligonucleotides listed in [Figure 2](#fig2){ref-type="fig"}B are shown in [Figure 4](#fig4){ref-type="fig"}A. Note that the frequencies of mutant appearance increased during the runs from 2.8 × 10^−3^ (1 cycle) to 9.3 × 10^−2^ (10 cycles) in the case of *gyrA*, and from 4.8 × 10^−2^ to 2.0 × 10^−1^ for *pyrF* under the same conditions. In the best-case scenario (i.e., gene *rpsL*), the frequencies multiplied by 24-fold, reaching a remarkable 21%. After the 10th cycle, these figures are thus close to the rates reported in *E. coli* with the archetypal Red-β system of phage lambda and also to the theoretical limit of recombineering frequencies (25%) that stems from segregation of one allelic change after two rounds of genome replication ([@bib41], [@bib29]). It is worth mentioning that control strain *P. putida* EM42 harboring insertless vector pSEVA2314---but transformed with the same mutagenic oligonucleotides---gave rise to recombineering frequencies ∼ 1 × 10^−5^/1 × 10^−6^ mutants/viable cells per cycle for single changes ([Figure S1](#mmc1){ref-type="supplementary-material"}). Given that these background levels are higher with thermal induction than with chemical induction ([@bib33]), it is plausible that heat shock intrinsically improves recombineering regardless of the action of heterologous recombinases. As a matter of fact, purely endogenous ssDNA recombineering at significant frequencies has been reported in a variety of Gram-negative bacteria, including *E. coli* and *Pseudomonas syringae* ([@bib38]), a fact that plays in our favor for establishing the methodology in *P. putida.*Figure 4Editing Efficiencies HEMSE(A) Editing efficiencies of single changes were assayed applying 10 cycles of HEMSE to *P. putida* EM42 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) using an equimolar mixture of oligos SR, NR, RR, PR, and CR. After recovery steps of cycles n^o^ 1 (C-I), n^o^ 5 (C-V), and n^o^ 10 (C-X), appropriate dilutions of the cultures were plated on LB to estimate viable cells and also on LB solid media supplemented with Sm, Nal, Rif, 5FOA-Ura, or benzoate to enumerate allelic replacements. Colonies growing on Sm, Nal, Rif, or 5FOA-Ura were counted as allelic changes, whereas brown, catechol-accumulating colonies growing in LB-benzoate were counted as *catA*-I^-^ clones (see phenotype in [Figure S2](#mmc1){ref-type="supplementary-material"}). Recombineering frequencies of single replacements at each cycle were normalized to 10^9^ viable cells, and the media of two independent replicas were plotted with standard deviations. Absolute recombineering frequencies (mutants per viable cell) are also depicted over the bars.(B) From the same experiments, editing efficiencies of multiple changes were analyzed. Dilutions of C-I, C-V, and C-X were plated on LB-SmNalRif-5FOA-Ura and LB-SmNalRif-5FOA-Ura-benzoate solid media, allowing the estimation of, respectively, quadruple (Sm^R^ Nal^R^ Rif^R^*pyrF*) and quintuple (Sm^R^ Nal^R^ Rif^R^*pyrF*^−^*catA*-I^-^) editions. Results are represented as in (A).(C) A representative plate of quintuple screening at C-X is shown. The zoom-up shows colonies with the characteristic dark brown phenotype of *catA*-I^-^ clones.

The most remarkable outcome of the operations shown in [Figure 4](#fig4){ref-type="fig"}A was that such high figures enabled manual screening of inconspicuous mutations, thus avoiding the need of adding a genetic counterselection device (e.g., CRISPR/Cas9) for identifying rare changes. As these results accredited the value of multi-cycling thermoinduction of the bicistronic *rec2*-*mutL*~E36K~^PP^ operon of pSEVA2314-*rec2*-*mutL*~E36K~^PP^ for raising ssDNA recombineering efficiency, the next obvious question was whether the high figures could afford simultaneous multi-site genomic editing with mixtures of mutagenic oligos, in a fashion reminiscent of the MAGE process available for *E. coli*.

Multi-site Editing of Non-Adjacent Genomic Locations {#sec2.3}
----------------------------------------------------

Given average individual mutation rates of 10% after 10 thermal recombineering cycles and assuming they are separately maintained when cells face a cocktail of mutagenic oligonucleotides one can predict frequencies of 1% double changes all the way to 0.001% mutants (1 × 10^−5^) of genomes with all the five changes in the absence of any phenotypic advantage. To test this prediction, we subjected a culture of *P. putida* EM42 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) to 10 cycles of thermo-induced recombineering (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}) with re-transformation in each cycle with an equimolar mixture of oligos SR, NR, RR, PR, and CR ([Figure 2](#fig2){ref-type="fig"}B; [Table S1](#mmc1){ref-type="supplementary-material"}) so that all possible changes could be entered in the same cells. Emergence of multiple (i.e., quadruple and quintuple) mutations in the population was then monitored at cycles I, V, and X and their frequencies recorded. [Figure 4](#fig4){ref-type="fig"}B shows the results of such a procedure. The data exposed a good match between the theoretical expectation of multiple changes and the actual figures, although the evolution of the mutation rates was not linear. At cycle \#1, single changes showed recombineering frequencies barely below 1 × 10^−2^ mutants per viable cell. If we take that as a reference, theoretical frequencies of acquisition of four and five changes would be 1 × 10^−8^ and 1E^−10^ respectively, whereas the actual numbers were way higher (6 × 10^−6^ and 2 × 10^−7^). By cycle \#5, single changes reached average recombineering above 5 × 10^−2^. The gross theoretical prediction for simultaneous appearance of four and five changes would be as low as 6 × 10^−6^ and 3 × 10^−7^. Yet, again, the actual experiments yield 1.3 × 10^−4^ and 2.3 × 10^−6^ mutants per viable cell for quadruple and quintuple mutants. By cycle \#10, however, the scenario was different. Single changes appeared at frequencies ∼ 1 × 10^−1^, close to the theoretical maximum of recombineering efficiency (2.5 × 10^−1^). In this case, predicted frequencies for four and five changes were 1 × 10^−4^ and 1 × 10^−5^, which were very similar to the actual numbers delivered by the experiment, i.e., 2 × 10^−4^ and 6 × 10^−6^.

The aforementioned results suggested that during the first five recombineering cycles a strong co-selection phenomenon occurs. Appearance of multiple mutations is 2--3 logs higher than expected, suggesting that cells undergoing ssDNA incorporation in specific loci are more prone to incorporate changes in other genomic locations. This phenomenon, which has been observed before ([@bib7], [@bib15]), could be due to differences in the ability of single cells in a population to take up exogenous ssDNA upon electroporation. Regardless of the specific mechanisms, the results of [Figure 4](#fig4){ref-type="fig"}B show that multi-cycle recombineering boosts mutagenic frequencies through single to quintuple changes. Yet, whereas 10 cycles appear to reach saturation at single sites, it is plausible that additional runs could enrich further the population in multi-edited bacterial cells. Taken together, the experiments of [Figure 4](#fig4){ref-type="fig"} document the power of the hereby described method for simultaneously targeting five genomic sites of *P. putida* for desired mutations. On this basis we propose to call the entire workflow high-efficiency multi-site genomic editing (or HEMSE). The method is conceptually comparable to MAGE developed for *E. coli* ([@bib41]), but it lacks (thus far) the automation aspect.

As a growing culture of *P. putida* in lysogeny broth (LB) typically ranges from 10^8^ to 10^9^ cells/mL from early exponential to early stationary phase, we speculated that the maximum number of genes that could be edited in a HEMSE experiment of this sort with mixed oligos in the absence of any selective advantage or phenotypic screening could be ∼ 8--9. This is clearly not enough for massive changes of the sort necessary, e.g., for recoding a whole genome ([@bib17]) or reassigning/erasing specific triplets ([@bib32]). Fortunately, in most typical metabolic engineering endeavors, the issue is not so much entering many defined mutations in given chromosomal sites but fostering the system to explore a solution space by letting it come up with many combinations---the most successful of which can be enriched and subject to further mutation rounds. This effect can be exacerbated if the mutagenic oligos boost the diversification of, e.g., regulatory sequences, so their combination generates fluctuations in the stoichiometry of a multi-gene pathway ([@bib16])---or they create variants of the same protein with different activities by diversifying specific segments. The technical issue shared by all these scenarios is the focusing of the diversification in a defined sequence window of the genomic DNA. In this context the question is whether the above-described HEMSE is instrumental to this end also---as the recombineering-based method to the same end called DIvERGE is in *E. coli* and related enterobacteria ([@bib30]).

Diversification of the SD Motif Context Creates New Functional RBSs in *P. putida* {#sec2.4}
----------------------------------------------------------------------------------

To have a tractable proxy of generation *in vivo* of large libraries of functional DNA sequences in the *P. putida* genome, the experimental setup shown in [Figure 5](#fig5){ref-type="fig"} was developed. In it, a Tn*7* mini-transposon vector was inserted with the *gfp* gene downstream of the constitutive promoter P~*EM7*~ but lacking a recognizable Shine-Dalgarno (SD) sequence for translation initiation. The hybrid transposon was subsequently inserted in the cognate *att*Tn*7* site of the *P. putida* EM42 chromosome (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}) from which it was expectedly unable to produce any detectable fluorescence. The resulting strain (*P. putida* TA245, [Table S2](#mmc1){ref-type="supplementary-material"}) was transformed with pSEVA2314-*rec2*- *mutL*~E36K~^PP^ and used in recombineering experiments with oligonucleotides designed for creating ribosomal binding site (RBSs) variants. The business parts of such oligonucleotides are shown in [Figure 5](#fig5){ref-type="fig"}B. As controls we used oligos named RBS-C~6~ and RBS-C~9~. These ssDNA enter, respectively, a short and an extended SD sequence, 8 bp upstream of the start codon of the *gfp* gene, using as a reference the *P. putida* 16S ribosomal gene and containing the core for optimal translation of 5′-GAGG-3′ ([@bib36], [@bib19], [@bib14]). For RBS diversification we used oligonucleotides RBS-Deg~6~ and RBS-Deg~9~ ([Figure 5](#fig5){ref-type="fig"}B), which include soft randomized sequences with discrete changes R (A or G) that cover six degenerated positions with a potential to generate 64 (= 2^6^) combinations. This was expected to create a large population of RBS of different efficacies, which could be quantified through fluorescent emission of individual cells.Figure 5Diversification of the *gfp* Shine-Dalgarno Motif(A) A mini-Tn*7* transposon bearing the *gfp* gene devoid of its original SD sequence and under the control of the constitutive P~*EM7*~ promoter was constructed. The elements depicted are: Tn*7*-L and Tn*7*-R, left and right Tn*7* sites; T~0~ and T~1~, transcriptional terminators; Gm^R^, gentamicin resistance gene; P~*EM7*~, constitutive promoter; GFP, green fluorescent protein gene. A blue arrow represents the target region of recombineering oligonucleotides aimed to reconstruct the *gfp* ribosome-binding site (shown as a red square).(B) Partial sequence of the four recombineering oligonucleotides ([Table S1](#mmc1){ref-type="supplementary-material"}) designed to introduce SD motifs upstream of the *gfp* gene. RBS-C~6~ and RBS-C~9~ insert, respectively, the semi-canonical AGGAGG and the canonical TAAGGAGGT SD motifs eight nucleotides upstream the ATG start codon of the *gfp* (underlined); RBS-Deg~6~ and RBS-Deg~9~ insert, the randomized sequences RRRRRR and TARRRRRRT, where R stands for A (adenine) or G (guanine). Each degenerated oligonucleotide comprises a pool of 64 variants (2^6^) with all possible combinations A/G.(C) The mini-Tn*7* device was inserted in the *att*Tn*7* site of *P. putida* EM42. Upon transformation with pSEVA2314-*rec2*-*mutL*~E36K~^PP^, the resulting strain *P. putida* TA245 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) was subjected to one HEMSE cycle with the recombineering oligos in independent experiments. After plating in LB-GmKm-charcoal, GFP-positive clones were identified. A plate from the screening of RBS-Deg~9~ is also shown, with a magnification of a fluorescent colony.

For the experiments described in the following discussion, *P. putida* TA245 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) was separately subject to one recombineering cycle with each of four oligos of [Figure 5](#fig5){ref-type="fig"}B, after which cells were diluted and plated in charcoal-LB agar for easing visual detection of colonies emitting low fluorescence on a black background. Positive controls RBS-C~6~ and RBS-C~9~ allowed the estimation of editing frequencies as GFP^+^ cells/total number of cells, which resulted in 5.9 × 10^−4^ and 9.9 × 10^−4^, respectively. Those values were relatively low when compared with the recombineering efficiencies reported earlier for single changes (∼1 × 10^−2^). This could be possibly due to the shorter homology arms of the oligos (30 nucleotides \[nts\]) and the extended sequence inserted between them ([@bib4]). Yet, these figures provided a reference for subsequent quantification of the effect of soft-randomized oligos RBS-Deg~6\ and~ RBS-Deg~9~. After treatment with these, cultures were diluted and plated for inspection of ∼9,000 colonies resulting of each recombineering experiment. Visual screening of the colonies revealed the appearance of 67 and 53 fluorescent clones coming, respectively, from experiments with RBS-Deg~6~ and RBS-Deg~9~. These 120 clones were picked up for further analysis. PCR and sequencing of the region upstream the *gfp* gene allowed identification of 14 variants of RBS-Deg~6~ and 17 variants of RBS-Deg~9~, the GFP levels of which were measured by flow cytometry. The results plotted in [Figure 6](#fig6){ref-type="fig"} show that the different variants delivered emissions ranging from very low to high fluorescent levels across a 20-fold change span. It is worth highlighting that the best RBS of the series (Strain Code \#33, [Figure 6](#fig6){ref-type="fig"}) has a perfect match with the complementary sequence of the last 9 nts of the 16S ribosomal RNA of *P. putida* (PP_16SA). Other clones (e.g., \#32; RBS = 5′-AAGGAG-3′) also displayed high fluorescence levels. Interestingly, a few productive variants contained the same 6-nt sequence in the degenerated region regardless of the type of randomized oligo (e.g., \#32 = \#30, \#26 = \#16, \#14 = \#11, and \#23 = \#10). Although most high-signal variants belong to the longer RBS-C~9~-borne clones, a comparison of signals does not support the hypothesis that longer complementarity to the 16S ribosomal sequence correlates with more efficient translation. Other factors have been proposed to affect translation efficacy of RBS variants, such as the stability and secondary structure of RNA and transcriptional efficiency ([@bib9], [@bib35]). Regardless of the possible biological significance of the results, the data of [Figure 6](#fig6){ref-type="fig"} certifies the efficacy of the HEMSE platform to generate diversity in specific genomic segments---a welcome feature that can doubtless be multiplexed to other chromosomal locations as required.Figure 6Characterization of the Diversified Library of SD SequencesThe screening of the HEMSE experiments performed in *P. putid*a TA245 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^) with RBS-Deg~6~ and RBS-Deg~9~ yielded 31 variants in the ribosome-binding site of the *gfp* gene. The GFP expression of this library was analyzed by flow cytometry including two negative controls: *P. putida* EM42 (Strain \#1), in which there is no *gfp* gene, and the ancestral strain *P. putid*a TA245 (pSEVA2314-*rec2*-*mutL*~E36K~^PP^), harboring the mini-Tn*7* and the *gfp* gene but lacking the original SD sequence (Strain \#2). The plot shows the mean fluorescent emission of individual clones from two biological replicas with standard deviations. A Strain Code was assigned to each variant analyzed, and the putative SD sequence identified 8 nts upstream of the *gfp* start codon is shown. Variants showing identical sequence in the randomized region are highlighted with the same color. A plate of LB-charcoal agar with streaks of the two controls and three representative clones exhibiting low, medium, and high signal rates (\#7, \#25, and \#33, respectively) is also depicted under UV light.

Discussion {#sec3}
==========

In this work we have merged and adapted to *P. putida* and in a single platform three of the most efficacious genetic tools available to metabolic engineers for generating diversity *in vivo* focused on a predetermined number of chromosomal DNA segments: ssDNA recombineering ([@bib41]), portable MAGE ([@bib29]), and DIvERGE ([@bib30]). Although conceptually identical to such methods already applied to *E. coli*, their recreation in a non-enterobacterial species involved (1) the search and testing of functional equivalents of the parts involved but recruited from *Pseudomonas* genomes and (2) adaptation and optimization to the distinct physiology of the species and strain at stake. Although we have not made a side-by-side comparison of the frequencies resulting from standard MAGE in *E. coli* and the ones presented in this work, numbers in the range of 10% replacements after 10 recombineering cycles could be sufficient to implement the same powerful method in *P. putida*. We are reluctant, however, to use the same acronym, because the automation feature is not in sight and the multiplexing is still problematic with the current efficiencies.

One can envision various ways through which HEMSE could be further improved. End-terminal degradation of the mutagenic oligos *in vivo* does not seem to be an issue: performance of 5′-phosphorothioated ssDNA (which cannot be degraded by exonucleases, [@bib41]) is indistinguishable from non-phosphorothioated equivalents ([@bib4]). However, the nature and origin of the recombinase that catalyzes invasion of the DNA replication fork by the synthetic oligo makes a considerable difference ([@bib8]). It is possible that such recombinases act in concert with additional endogenous proteins that could be characteristic of each species ([@bib6], [@bib43]). It seems thus desirable that future alternatives to the Rec2 activity encoded in pSEVA2314-*rec2*-*mutL*~E36K~^PP^ ([Figure 1](#fig1){ref-type="fig"}) are mined in species-specific *Pseudomonas* genomes and phages---by themselves or in combination with other complementary genes. It should be straightforward to then replace the *rec2* of pSEVA2314-*rec2*-*mutL*~E36K~^PP^ by the improved counterparts, should they appear (e.g., [@bib42]), while maintaining the rest of the hereby described HEMSE protocol.

Limitations of the Study {#sec3.1}
------------------------

As stated, one key bottleneck for implementing ssDNA recombineering in non-enteric bacteria is the efficacy of the core recombinase adopted in the experimental workflow. The work presented in this article is based on the one named Rec2, which emerged as the best in a limited bioinformatic and wet survey of ssDNA-binding proteins able to promote ssDNA invasion of the chromosomal replication fork ([@bib33]). However, it is most likely that other recombinases, whether naturally occurring or purposely engineered, may work better and could easily replace the Rec2 variant in our genome-editing pipeline whenever available. A second limitation is the somewhat poor ability of *P. putida* to capture exogenously added DNA, let alone ssDNA, as required for the hereby described method. Any progress in making this species---or any other---a better recipient of synthetic DNA will instantly translate in improved recombineering frequencies. Finally, the whole experimental workflow for multiple-site ssDNA recombineering is thus far restricted to manual implementation of the corresponding cycles. Despite the potential for automation claimed in the earliest description of MAGE ([@bib41]), the cell separation step necessary for transforming bacteria with the mutagenic oligonucleotides still remains as a technical bottleneck that needs to be satisfactorily solved.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1 and S2, and Tables S1--S3
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